The high-dose regimen of SPINRAZA (nusinersen) is approved in the European Union and Japan. The high-dose regimen is under review with the United States Food and Drug Administration (FDA) and has a ...
Comparative Study of Chemotherapy Tolerance and Immune Function Changes in Gynecological Malignancy Patients with HIV ...
Affecting approximately 262 million people worldwide, asthma is a chronic condition of the lungs that causes airway inflammation. 1. Typical symptoms include: Breathlessness; Whee ...
Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced preliminary, unaudited fourth quarter and full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results